# EDGAR Filing Document

**Accession Number:** 0001835615
**File Stem:** 0001213900-26-019927
**Filing Date:** 2026-2
**Character Count:** 2104
**Document Hash:** 1220875a489a018edd9b11e4c9f673e6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-019927.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0001213900-26-019927

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260224

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Meihua International Medical Technologies Co., Ltd.
- **CENTRAL INDEX KEY:** 0001835615
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 88 TONGDA ROAD
- **STREET 2:** TOUQIAO TOWN, GUANGLING DISTRICT
- **CITY:** YANGZHOU
- **STATE:** F4
- **ZIP:** 225000
- **BUSINESS PHONE:** (86) 0514-89800199

**MAIL ADDRESS:**
- **STREET 1:** 88 TONGDA ROAD,
- **STREET 2:** TOUQIAO TOWN, GUANGLING DISTRICT
- **CITY:** YANGZHOU
- **STATE:** F4
- **ZIP:** 225000

**Meihua International Medical Technologies Co., Ltd.**

88 Tongda Road, Touqiao Town, Guangling District

Yangzhou, China, 225000

<u>Via EDGAR</u>

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C., 20549

Attention: Nicholas O'Leary <br>

February 24, 2026

---

| | |
|:---|:---|
| **Re:** | **Meihua International Medical Technologies Co., Ltd.** |
|  | **Registration Statement on Form F-3 (File No. 333-293682)** |
|  | **Filed on February 24, 2026** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Meihua International Medical Technologies Co., Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement, so that it will become effective at 5:00 p.m., Eastern Time, on February 25, 2026, or as soon as thereafter practicable.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| /s/ Leyi Lee | /s/ Leyi Lee |
| Name: | Leyi Lee |
| Title: | Chief Executive Officer |

---

cc: Joan Wu, Esq. <br> Hunter Taubman Fischer & Li LLC